|
GPX4 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | <1E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.62447832963153E-12 |
| Normal-vs-Stage2 |
2.4870999704163E-09 |
| Normal-vs-Stage3 |
1.62436730732907E-12 |
| Normal-vs-Stage4 |
1.62458935193399E-12 |
| Stage1-vs-Stage2 |
5.242000E-01 |
| Stage1-vs-Stage3 |
2.928400E-02 |
| Stage1-vs-Stage4 |
1.520170E-02 |
| Stage2-vs-Stage3 |
5.390400E-02 |
| Stage2-vs-Stage4 |
2.086400E-02 |
| Stage3-vs-Stage4 |
6.302400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
2.54829999990491E-07 |
| Normal-vs-Asian |
3.25870441741927E-11 |
| Caucasian-vs-AfricanAmerican |
8.924200E-01 |
| Caucasian-vs-Asian |
9.889200E-01 |
| AfricanAmerican-vs-Asian |
9.210800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62436730732907E-12 |
| Normal-vs-Female |
<1E-12 |
| Male-vs-Female |
1.628150E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(41-60Yrs) |
1.11022302462516E-16 |
| Normal-vs-Age(61-80Yrs) |
<1E-12 |
| Normal-vs-Age(81-100Yrs) |
1.797980E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.251000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.392600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.006600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.579000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.524600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.991200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.754570E-01 |
| Classical-VS-Follicular |
6.19339999999857E-05 |
| Classical-VS-Other |
9.043400E-01 |
| Classical-VS-Normal |
<1E-12 |
| Tall-VS-Follicular |
2.377400E-04 |
| Tall-VS-Other |
4.428200E-01 |
| Tall-VS-Normal |
1.71570535556498E-11 |
| Follicular-VS-Other |
2.074200E-01 |
| Follicular-VS-Normal |
2.85238499486695E-12 |
| Other-VS-Normal |
4.319700E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.62447832963153E-12 |
| Normal-vs-N1 |
1.63491442606301E-12 |
| N0-vs-N1 |
5.937600E-02 |
|
|
